Status | Study |
Recruiting |
Study Name: A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia Condition: Immune Thrombocytopenia Date: 2012-03-29 Interventions: Drug: Decitabine Decitabine 3.5mg/m2,ivdrip,qd x 3d, every four weeks for one cycle. It wi |
Withdrawn |
Study Name: A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia. Condition: Purpura, Thrombocytopaenic, Idiopathic Date: 2011-09-22 Interventions: Drug: Belimumab 10 mg /kg give |
Recruiting |
Study Name: End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia Condition: Immune Thrombocytopenia Date: 2011-06-13 Interventions: Drug: Discontinuation of eltrombopag Observation of subjects as they discontinue the use of eltrombopag |
Completed |
Study Name: High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) Condition: Purpura, Thrombocytopenic, Idiopathic Date: 2011-05-17 Interventions: Drug: Prednisone Prednisone, p |
Withdrawn |
Study Name: Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia Condition: Purpura, Thrombocytopenic, Idiopathic Date: 2011-03-17 Interventions: Drug: rhIL-11 Recombinant Human Interleukin-11 (rhIL-11) Combinating Low-dose Rituximab |
Completed |
Study Name: The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia. Condition: Purpura, Thrombocytopenic, Idiopathic Aut Date: 2010-04-05 |
Completed |
Study Name: Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Condition: Idiopathic Thrombocytopenic Purpura Purpu Date: 2009-01-22 Interventions: Drug: Eltrombopag oral tablets Eltrombopag oral tablets once daily |
Completed |
Study Name: Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP) Condition: Purpura, Thrombocytopenic, Idiopathic Date: 2008-06-25 Interventions: Drug: Fostamatinib Disodium / R935788 R935788 tablets |
Completed |
Study Name: Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Condition: Chronic Idiopathic Thrombocytopenic Purpura Date: 2007-10-05 Interventions: Drug: SB-497115-GR 12.5mg SB-4 |
Completed |
Study Name: Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) Condition: Chronic Idiopathic Thrombocytopenic Purpura Date: 2007-02-27 Interventions: Drug: Placebo Placebo Tablets |